These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 37418117

  • 21. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
    Xu XX, Cheng J, Xu WG, Dai D, Song XY, Ma WC, Zhu L, Zhu X.
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
    [Abstract] [Full Text] [Related]

  • 22. Comparison of 18F-FDG PET/CT imaging with different dual time 18F-FDG PET/CT with forced diuresis in clinical diagnosis of prostate cancer.
    Yu L, Huang S, Wu S, Yue J, Yin L, Lin Z.
    Medicine (Baltimore); 2023 Jan 13; 102(2):e32331. PubMed ID: 36637950
    [Abstract] [Full Text] [Related]

  • 23. Reduction in ¹⁸F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis.
    Osborne MT, Hulten EA, Singh A, Waller AH, Bittencourt MS, Stewart GC, Hainer J, Murthy VL, Skali H, Dorbala S, Di Carli MF, Blankstein R.
    J Nucl Cardiol; 2014 Feb 13; 21(1):166-74. PubMed ID: 24307261
    [Abstract] [Full Text] [Related]

  • 24. Influence of scan time point and volume of intravenous contrast administration on blood-pool and liver SUVmax and SUVmean in [18F] FDG PET/CT.
    Schoen M, Braun T, Manava P, Ludwigs S, Lell M.
    Nuklearmedizin; 2018 Apr 13; 57(2):50-55. PubMed ID: 29590675
    [Abstract] [Full Text] [Related]

  • 25. Feasibility of 18FDG PET in the cardiac inflammation.
    Osiecki S, Sterliński M, Marciniak-Emmons M, Dziuk M.
    Int J Cardiovasc Imaging; 2021 Mar 13; 37(3):1097-1104. PubMed ID: 33063243
    [Abstract] [Full Text] [Related]

  • 26. 18F-fluorodeoxyglucose positron emission tomography is useful for the diagnosis of intraocular sarcoidosis in patients with a normal CT scan.
    Chauvelot P, Skanjeti A, Jamilloux Y, de Parisot A, Broussolle C, Denis P, Ramackers JM, Giammarile F, Kodjikian L, Seve P.
    Br J Ophthalmol; 2019 Nov 13; 103(11):1650-1655. PubMed ID: 30658987
    [Abstract] [Full Text] [Related]

  • 27. Complete resolution of focal-on-diffuse myocardial activity pattern on FDG PET-CT by prolonging the dietary preparation protocol in cardiac sarcoidosis.
    Kherajani P, Farag AA, Morgan WS, Hage FG, Bhambhvani P.
    J Nucl Cardiol; 2023 Dec 13; 30(6):2525-2530. PubMed ID: 37524998
    [Abstract] [Full Text] [Related]

  • 28. Does dual-time-point 18F-FDG PET/CT scan add in the diagnosis of hepatocellular carcinoma?
    Wu B, Zhao Y, Zhang Y, Tan H, Shi H.
    Hell J Nucl Med; 2017 Dec 13; 20(1):79-82. PubMed ID: 28315913
    [Abstract] [Full Text] [Related]

  • 29. 18F-FDG gallbladder uptake: observation from a total-body PET/CT scanner.
    Calabro' A, Abdelhafez YG, Triumbari EKA, Spencer BA, Chen MS, Albano D, Cassim CR, Bertagna F, Dondi F, Cherry SR, Badawi RD, Sen F, Nardo L.
    BMC Med Imaging; 2023 Jan 10; 23(1):9. PubMed ID: 36627570
    [Abstract] [Full Text] [Related]

  • 30. Diagnostic value of quantitative assessment of cardiac 18F-fluoro-2-deoxyglucose uptake in suspected cardiac sarcoidosis.
    Lebasnier A, Legallois D, Bienvenu B, Bergot E, Desmonts C, Zalcman G, Agostini D, Manrique A.
    Ann Nucl Med; 2018 Jun 10; 32(5):319-327. PubMed ID: 29560563
    [Abstract] [Full Text] [Related]

  • 31. Relationship of Ketosis With Myocardial Glucose Uptake Among Patients Undergoing FDG PET/CT for Evaluation of Cardiac Sarcoidosis.
    Vidula MK, Selvaraj S, Rojulpote C, Bhattaru A, Kc W, Hansbury M, Schubert E, Clancy CB, Rossman M, Goldberg LR, Farwell M, Pryma D, Bravo PE.
    Circ Cardiovasc Imaging; 2024 Aug 10; 17(8):e016774. PubMed ID: 39082134
    [Abstract] [Full Text] [Related]

  • 32. Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by ¹⁸F- fluorodoexyglucose positron emission tomography?
    Mc Ardle BA, Birnie DH, Klein R, de Kemp RA, Leung E, Renaud J, DaSilva J, Wells GA, Beanlands RS, Nery PB.
    Circ Cardiovasc Imaging; 2013 Sep 10; 6(5):617-26. PubMed ID: 23884290
    [Abstract] [Full Text] [Related]

  • 33. Assessment of treatment response in cardiac sarcoidosis based on myocardial 18F-FDG uptake.
    Frischknecht L, Schaab J, Schmauch E, Yalamanoglu A, Arnold DD, Schwaiger J, Gruner C, Buechel RR, Franzen DP, Kolios AGA, Nilsson J.
    Front Immunol; 2023 Sep 10; 14():1286684. PubMed ID: 38077350
    [Abstract] [Full Text] [Related]

  • 34. Dual-time-point [18F]-FDG PET/CT in the diagnostic evaluation of suspicious breast lesions.
    Caprio MG, Cangiano A, Imbriaco M, Soscia F, Di Martino G, Farina A, Avitabile G, Pace L, Forestieri P, Salvatore M.
    Radiol Med; 2010 Mar 10; 115(2):215-24. PubMed ID: 20017002
    [Abstract] [Full Text] [Related]

  • 35. Accuracy of early and delayed FDG PET-CT and of contrast-enhanced CT in the evaluation of lung nodules: a preliminary study on 30 patients.
    Schillaci O, Travascio L, Bolacchi F, Calabria F, Bruni C, Cicciò C, Guazzaroni M, Orlacchio A, Simonetti G.
    Radiol Med; 2009 Sep 10; 114(6):890-906. PubMed ID: 19579015
    [Abstract] [Full Text] [Related]

  • 36. The added value of dual-time-point 18F-FDG PET/CT imaging in the diagnosis of colorectal cancer liver metastases.
    Mao W, Zhou J, Qiu L, Yin H, Tan H, Shi H.
    Abdom Radiol (NY); 2020 Apr 10; 45(4):1075-1081. PubMed ID: 31927618
    [Abstract] [Full Text] [Related]

  • 37. Diagnostic performance of total-body 18F-FDG PET/CT with fast 2-min acquisition for liver tumours: comparison with conventional PET/CT.
    Hu Y, Liu G, Yu H, Gu J, Shi H.
    Eur J Nucl Med Mol Imaging; 2022 Aug 10; 49(10):3538-3546. PubMed ID: 35344063
    [Abstract] [Full Text] [Related]

  • 38. The response of FDG uptake to immunosuppressive treatment on FDG PET/CT imaging for cardiac sarcoidosis.
    Ahmadian A, Pawar S, Govender P, Berman J, Ruberg FL, Miller EJ.
    J Nucl Cardiol; 2017 Apr 10; 24(2):413-424. PubMed ID: 27457527
    [Abstract] [Full Text] [Related]

  • 39. The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis.
    Lee PI, Cheng G, Alavi A.
    J Nucl Cardiol; 2017 Feb 10; 24(1):19-28. PubMed ID: 27813028
    [Abstract] [Full Text] [Related]

  • 40. Dual time point positron emission tomography/computed tomography scan in evaluation of intrathoracic lesions in an area endemic for histoplasmosis and with high prevalence of sarcoidosis.
    Kadaria D, Archie DS, SultanAli I, Weiman DS, Freire AX, Zaman MK.
    Am J Med Sci; 2013 Nov 10; 346(5):358-62. PubMed ID: 23276900
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.